Evaluating the Efficacy of Cysticlean 240 mg: A 12-Month Randomized, Placebo-Controlled Trial

Clinical Study: Cysticlean vs. Placebo

Randomized, Double-Blind, 12-Month Trial [cite: 4, 12]
51% Reduction in UTIs [cite: 16, 148]
7 Months Median UTI-Free Survival [cite: 150]
Zero Adverse Events Reported [cite: 18, 169]

Percentage of women suffering frequent recurrences (≥3 UTIs/year):

Cysticlean Group 3.8% [cite: 147, 181]
Placebo Group 51.3% [cite: 147, 184]

Want to see the science for yourself?

Explore the peer-reviewed data behind these results.

VIEW FULL CLINICAL STUDY →
  • Gold-standard randomized, double-blinded trial [cite: 4, 15]
  • Long-term efficacy tested on 160 women over 12 months [cite: 15, 48]
  • Proven safety with zero reported adverse events [cite: 18, 50]
Source: World Journal of Urology (2024). DOI: 10.1007/s00345-023-04741-0 [cite: 1] | Study Identifier: NCT03032003 [cite: 20]